Immune system

Israeli-founded AI biotech Immunai launches drug-discovery collaboration with Boehringer Ingelheim

The collaboration will use Immunai’s single-cell AI platform to identify T-cell targets in cancer and autoimmune diseases.

Medicine cabinet
A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021

Israeli-founded AI biotech Immunai expands AstraZeneca cancer collaboration

A guest sits in the outdoor sauna, gazing into the surrounding forest as the quiet heat blends seamlessly with the natural stillness of Slowness.

Just 30 minutes of sauna time tied to a sharper immune response

Kimchi

They ate these pickles for 3 months. And this is the amazing thing that happened to them


COVID-19: Exposure to weaker strains could be less severe - study

The findings reveal a possible answer for why some people are more resistant to COVID-19, especially young children.

Two genetically engineered T Cells (light green) attacking a cancer cell in red.

Israeli experts find possible key to avoid immune system’s ‘overreaction’

An “overreaction” of the immune system, the so-called “Cytokine storm” has also been one of the causes of severe disease or death in many coronavirus patients.

Two genetically engineered T Cells (light green) attacking a cancer cell in red.

UAE-backed Israeli start-up aims to be ‘Google Maps’ of immune system

“This is an era of precision medicine, and Immunai, together with other companies, is helping shape the next generation of medicine relying on big data and biology.”

Noam Solomon, CEO & Co-Founder, Immunai